246 related articles for article (PubMed ID: 29672472)
21. A real world comparison of HepB (Engerix-B®) and HepB-CpG (Heplisav-B®) vaccine seroprotection in patients receiving maintenance dialysis.
Manley HJ; Aweh G; Frament J; Ladik V; Lacson EK
Nephrol Dial Transplant; 2023 Feb; 38(2):447-454. PubMed ID: 35150277
[TBL] [Abstract][Full Text] [Related]
22. Update: Shortened Interval for Postvaccination Serologic Testing of Infants Born to Hepatitis B-Infected Mothers.
Schillie S; Murphy TV; Fenlon N; Ko S; Ward JW
MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(39):1118-20. PubMed ID: 26447601
[TBL] [Abstract][Full Text] [Related]
23. Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel.
Nelson NP; Link-Gelles R; Hofmeister MG; Romero JR; Moore KL; Ward JW; Schillie SF
MMWR Morb Mortal Wkly Rep; 2018 Nov; 67(43):1216-1220. PubMed ID: 30383742
[TBL] [Abstract][Full Text] [Related]
24. [Study on antibody response to revaccination of hepatitis B vaccine among firstly low-response adults].
Feng Y; Yan BY; Zhang L; Lü JJ; Liu JY; Gong XH; Cui FQ; Liang XF; Chen SY; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Sep; 46(9):813-7. PubMed ID: 23157885
[TBL] [Abstract][Full Text] [Related]
25. Preventing Hepatitis B Virus Infection Among U.S. Military Personnel: Potential Impact of a 2-Dose Versus 3-Dose Vaccine on Medical Readiness.
Oelschlager KA; Termini MS; Stevenson C
Mil Med; 2023 Jul; 188(7-8):e2067-e2073. PubMed ID: 36525511
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
Bailey CL; Smith V; Sands M
Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
[TBL] [Abstract][Full Text] [Related]
27. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
[TBL] [Abstract][Full Text] [Related]
28. Practice Alert: ACIP vaccine update.
Campos-Outcalt D
J Fam Pract; 2018 Mar; 67(3):155-158. PubMed ID: 29509821
[TBL] [Abstract][Full Text] [Related]
29. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
Haber P; Moro PL; Ng C; Lewis PW; Hibbs B; Schillie SF; Nelson NP; Li R; Stewart B; Cano MV
Vaccine; 2018 Jan; 36(4):559-564. PubMed ID: 29241647
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study.
Girndt M; Plüer M; Dellanna F; Michelsen AK; Beige J; Toussaint K; Wehweck HJ; Koch M; Hafezi Rachti S; Faust J; Bosselmann HP; Witzke O; Janssen RS;
Hum Vaccin Immunother; 2022 Nov; 18(6):2136912. PubMed ID: 36269938
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
[TBL] [Abstract][Full Text] [Related]
32. CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study.
Cooper CL; Davis HL; Morris ML; Efler SM; Adhami MA; Krieg AM; Cameron DW; Heathcote J
J Clin Immunol; 2004 Nov; 24(6):693-701. PubMed ID: 15622454
[TBL] [Abstract][Full Text] [Related]
33. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
[TBL] [Abstract][Full Text] [Related]
34. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
[TBL] [Abstract][Full Text] [Related]
35. Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():768-71. PubMed ID: 23013723
[TBL] [Abstract][Full Text] [Related]
36. Heplisav-B vaccination for the prevention of hepatitis B virus infection in adults in the United States.
Splawn LM; Bailey CA; Medina JP; Cho JC
Drugs Today (Barc); 2018 Jul; 54(7):399-405. PubMed ID: 30090877
[TBL] [Abstract][Full Text] [Related]
37. Preventing hepatitis B virus infection among healthcare professionals: potential impact of a 2-dose versus 3-dose vaccine.
Stevenson C; Youn JH; Hayney MS; David C
Hum Vaccin Immunother; 2021 Nov; 17(11):4567-4577. PubMed ID: 34505827
[TBL] [Abstract][Full Text] [Related]
38. New hepatitis B vaccine formulated with an improved adjuvant system.
Kundi M
Expert Rev Vaccines; 2007 Apr; 6(2):133-40. PubMed ID: 17408363
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women.
Ko SC; Schillie SF; Walker T; Veselsky SL; Nelson NP; Lazaroff J; Crowley S; Dusek C; Loggins K; Onye K; Fenlon N; Murphy TV
Vaccine; 2014 Apr; 32(18):2127-33. PubMed ID: 24560676
[TBL] [Abstract][Full Text] [Related]
40. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
